http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-062894-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| filingDate | 2007-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35c6c4a298c7f7afaca6efd4008a67e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26cc828f74061835eff291d74aa3bc1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0730085ce2279c582a6d088724ddaa32 |
| publicationDate | 2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-062894-A1 |
| titleOfInvention | FORMULATIONS FOR THERAPEUTIC ESTIMULATION HORMONE THERAPEUTIC ADMINISTRATION (THS) |
| abstract | The present description generally refers to formulations containing the active ingredient of thyroid stimulation hormone (TSH) that have modified pharmacokinetic profiles compared to the prior art formulations Claim 1: A method of treating a pathological state of the thyroid in a patient who needs it, which comprises administering to the patient an effective amount of a pharmaceutical composition comprising an effective amount of TSH and an effective amount of a pharmaceutically acceptable polymer. Claim 26: A pharmaceutical composition comprising TSH and a pharmaceutically acceptable polymer that allows the modified release of TSH into the bloodstream of a patient, such that, when administered to the patient, the pharmaceutical composition provides an effective Tmax of TSH in the patient's serum that is at least about 20% longer than the effective Tmax of TSH in the patient's serum when a corresponding aqueous solution of TSH is administered. Claim 33: The pharmaceutical composition of claims 26 or 27, wherein the pharmaceutically acceptable polymer is sodium carboxymethyl cellulose. Claim 51: Use of a composition according to any of claims 26, 27, 38 and 42-44 for the manufacture of a medicament for treating a pathological state of the thyroid. |
| priorityDate | 2006-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691 |
Total number of triples: 25.